DeepSeek-R1 charts a new path for AI through explaining its own reasoning process. Why does this matter and how will it benefit the world?

Acellera Therapeutics focuses on drug discovery by merging AI-driven innovation with computational scaleability, aiming to ...

A collaborative study between researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...

Scientists have pioneered a groundbreaking method to combat snake venom using newly designed proteins, offering hope for more ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

This piece is part of a series that dives deeper into the most prevalent themes of this year’s iteration of our flagship research piece, Charting Disruption. Click to read.

Via AI methodologies, trial sponsors can simulate outcomes for different clinical development pathway scenarios to evaluate ...

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

While the presidential transition commanded headlines this week, equally significant shifts were occurring in AI technology. Just hours before Donald Trump’s inauguration, DeepSeek released its latest ...